In recent trading session, Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) saw 2,274,696 shares changing hands with its beta currently measuring 1.38. Company’s recent per share price level of $0.75 trading at $0.01 or 2.25% at recent trade assigns it a market valuation of $99.21 Million. That current trading price of TNXP’s stock is at a discount of -526.67% from its 52-week high price of $4.7 and is indicating a premium of 48% from its 52-week low price of $0.39. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 4.11 Million shares which gives us an average trading volume of 21.15 Million if we extend that period to 3-months.

For Tonix Pharmaceuticals Holding Corp. (TNXP), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2. Splitting up the data highlights that, out of 1 analysts covering the stock, none rated the stock as a Sell while none recommended an Overweight rating for the stock. None suggested the stock as a Hold whereas 1 see the stock as a Buy. None analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.11 in the current quarter.

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) trade information

Upright in the green today for gaining 2.25%, in the last five days TNXP remained trading in the green while hitting it’s week-highest on Monday, Oct 12 when the stock touched $0.7749 price level, adding 3.01% to its value on the day. Tonix Pharmaceuticals Holding Corp.’s shares saw a change of -35.76% in year-to-date performance and have moved -2.12% in past 5-day. Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) showed a performance of -14.44% in past 30-days. Number of shares sold short was 992.64 Million shares which calculate 46.93 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of $3 to the stock, which implies a rise of 300% to its current value. Analysts have been projecting $3 as a low price target for the stock while placing it at a high target of $3. It follows that stock’s current price would jump +300% in reaching the projected high whereas dropping to the targeted low would mean a loss of 300% for stock’s current value.

Tonix Pharmaceuticals Holding Corp. (TNXP) estimates and forecasts

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 0% during past 5 years. In 2020, company’s earnings growth rate is likely to be around 92.8% while estimates for its earnings growth in next 5 years are of 0%